FDA 483 - Javier Pascual Lopez - October 24, 2025

An FDA inspection of Javier Pascual Lopez, a clinical investigator in Malaga, Spain, revealed a significant issue with the conduct of an investigation. The firm failed to adhere to its investigational plan, specifically regarding the blinding of treatment arms. Unblinded treatment information was found in source records, indicating a breach in study integrity.